Latest News

  • Northern Sydney leading the way with arthritis research and clinical care

    Northern Sydney leading the way with arthritis research and clinical care

    Posted on: 

    The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase. Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain. RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the

    Read more

    Category:     

  • New world leading technology to guide future bowel cancer treatment

    New world leading technology to guide future bowel cancer treatment

    Posted on: 

    Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer. Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best

    Read more

  • Recognition for the Kolling Director

    Recognition for the Kolling Director

    Posted on: 

    The Kolling’s Director of Research Professor Carolyn Sue has been awarded a Member of the Order of Australia (AM) in this year’s Queen’s Birthday Honours for her significant service to medicine, particularly mitochondrial disease. Carolyn is a highly accomplished neurologist and is internationally regarded for her work in both Parkinson’s and mitochondrial disease. Recently appointed

    Read more

    Category:     

  • Newsletter 2

    Newsletter 2

    Posted on: 

    Read more

    Category:     

  • Newsletter 1

    Newsletter 1

    Posted on: 

    Read more

    Category:     

  • New medication may offer long-acting relief for those with knee osteoarthritis

    New medication may offer long-acting relief for those with knee osteoarthritis

    Posted on: 

    A study has been launched to investigate the benefits of a new injectable medication for those with knee osteoarthritis. The condition can have a profound impact on a person’s life, leading to physical limitations, ongoing pain and joint instability. There are broader implications too which can make it difficult for those with the condition to

    Read more

  • Global focus on musculoskeletal health

    Global focus on musculoskeletal health

    Posted on: 

    Kolling researchers are part of an international team calling for musculoskeletal health to become a global priority, addressing a current lack of funding for the world’s leading cause of pain. The project team found the management of musculoskeletal health is under-prioritised despite its impact on the community, and devised an action plan to address this

    Read more

    Category: